3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Carboplatin
12
Bevacizumab
10
Radiotherapy
9
Paclitaxel
9
Erlotinib Hydrochloride
9
Pemetrexed
7
Docetaxel
5
Taxes
4
Cisplatin
4
pegfilgrastim
3
Gemcitabine
3
Cetuximab
3
Radiotherapy, Conformal
2
Filgrastim
2
veliparib
1
romidepsin
1
pegylated granulocyte colony-stimulating factor
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
Watchful Waiting
1
Vinorelbine
1
Topotecan
1
Thalidomide
1
Temozolomide
1
Surgical Procedures, Operative
1
Sorafenib
1
Selenomethionine
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pneumonectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Bronchiolo-Alveolar
×
sargramostim
×
Clear all
No trials found.